SARS-CoV-IN-2, identified by its CAS number 888958-26-7, is a chemical compound that has garnered attention in the context of antiviral research, particularly against coronaviruses. This compound functions as a protease inhibitor, specifically targeting the main protease (Mpro) of the SARS-CoV-2 virus, which is responsible for COVID-19. By inhibiting this enzyme, SARS-CoV-IN-2 disrupts the viral replication process, making it a potential therapeutic agent in the treatment of COVID-19. The compound is characterized by its specific molecular structure, which allows it to bind effectively to the active site of the protease. In terms of physical properties, detailed information such as solubility, melting point, and stability under various conditions would typically be assessed during its development and testing phases. As research continues, the efficacy, safety, and pharmacokinetics of SARS-CoV-IN-2 are critical areas of investigation to determine its potential role in clinical settings.

SARS-CoV-IN-2

888958-26-7: SARS-CoV-IN-2, identified by its CAS number 888958-26-7, is a chemical compound that has garnered attention in the context of antiviral research, particularly against coronaviruses. This compound functions as a protease inhibitor, specifically targeting the main protease (Mpro) of the SARS-CoV-2 virus, which is responsible for COVID-19. By inhibiting this enzyme, SARS-CoV-IN-2 disrupts the viral replication process, making it a potential therapeutic agent in the treatment of COVID-19. The compound is characterized by its specific molecular structure, which allows it to bind effectively to the active site of the protease. In terms of physical properties, detailed information such as solubility, melting point, and stability under various conditions would typically be assessed during its development and testing phases. As research continues, the efficacy, safety, and pharmacokinetics of SARS-CoV-IN-2 are critical areas of investigation to determine its potential role in clinical settings.

<p>SARS-CoV-IN-2 is a highly specific and potent antiviral inhibitor, which is chemically synthesized to target SARS-CoV-2, the virus responsible for COVID-19. This compound functions by interfering with the viral replication process, specifically targeting the viral 3CL protease enzyme, crucial for viral polyprotein cleavage. By inhibiting this protease, SARS-CoV-IN-2 effectively hampers the replication cycle of the virus, limiting its ability to proliferate within the host cells.</p>

<p>SARS-CoV-IN-2 is an effective SARS-CoV replication inhibitor</p>

CAS 888958-26-7

SARS-CoV-IN-2

SARS-CoV-IN-2

Ref: 3D-AS179347

SARS-CoV-IN-2

Ref: TM-T12838